Page last updated: 2024-12-10

snap 5114

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID10458835
CHEMBL ID75035
SCHEMBL ID18187570
MeSH IDM0243739

Synonyms (27)

Synonym
CHEMBL75035 ,
snap-5114
bdbm50039246
(s)-1-(2-(tris(4-methoxyphenyl)methoxy)ethyl)piperidine-3-carboxylic acid
(s)-1-{2-[tris-(4-methoxy-phenyl)-methoxy]-ethyl}-piperidine-3-carboxylic acid
HMS3268E15
NCGC00025217-02
157604-55-2
(s)-snap-5114
(s)-snap 5114
(3s)-1-{2-[tris(4-methoxyphenyl)methoxy]ethyl}piperidine-3-carboxylic acid
gtpl4677
1-[2-[tris(4-methoxyphenyl)methoxy]ethyl]-(s)-3-piperidinecarboxylic acid
AKOS024456666
DTXSID40440224
SR-01000597587-1
sr-01000597587
(s)-snap-5114, >=98% (hplc), solid
SCHEMBL18187570
Q27088834
(s)-snap5114
HY-103504
(3s)-1-[2-[tris(4-methoxyphenyl)methoxy]ethyl]piperidine-3-carboxylic acid
(s)-1-(2-(tris(4-methoxyphenyl)methoxy)ethyl)piperidine-3-carboxylicacid
CS-0028006
MS-29395
3-piperidinecarboxylic acid, 1-[2-[tris(4-methoxyphenyl)methoxy]ethyl]-, (3s)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (10)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 3A4Homo sapiens (human)IC50 (µMol)30.82700.00011.753610.0000AID1573769; AID1573771; AID759056
Sodium- and chloride-dependent GABA transporter 1Homo sapiens (human)IC50 (µMol)261.76130.01013.090310.0000AID1188930; AID205303; AID631073; AID764978
Sodium- and chloride-dependent GABA transporter 2Rattus norvegicus (Norway rat)IC50 (µMol)20.94650.00321.79008.3000AID205447; AID631076
Sodium- and chloride-dependent GABA transporter 1Mus musculus (house mouse)IC50 (µMol)89.62600.03712.19228.5114AID1156721; AID1192137; AID1195448; AID1272002; AID1498409; AID1573765; AID1615004; AID1736160; AID1778993; AID370903; AID595473; AID759056; AID764602
Sodium- and chloride-dependent GABA transporter 1Mus musculus (house mouse)Ki27.54230.02750.05310.1862AID1156726; AID1498407; AID1615003; AID764600
Sodium- and chloride-dependent GABA transporter 2Mus musculus (house mouse)IC50 (µMol)12.80331.41255.26838.1283AID1156723; AID1192141; AID1195450; AID1272004; AID1573769; AID370905; AID595474; AID759053
Sodium- and chloride-dependent GABA transporter 3Mus musculus (house mouse)IC50 (µMol)4.44051.54883.67618.1283AID1156724; AID1192143; AID1195451; AID1272005; AID1498412; AID1498414; AID1573771; AID1615008; AID1615010; AID1736158; AID1736188; AID1778999; AID1779000; AID370906; AID595475; AID759054
Sodium- and chloride-dependent betaine transporterMus musculus (house mouse)IC50 (µMol)350.96770.18003.188010.0000AID1195449; AID1272003; AID759055
Sodium- and chloride-dependent betaine transporterHomo sapiens (human)IC50 (µMol)106.16350.85116.052136.0000AID1188933; AID205304; AID631075; AID764975
Sodium- and chloride-dependent GABA transporter 3Homo sapiens (human)IC50 (µMol)3.42721.00004.13318.9200AID1188932; AID1573772; AID487217; AID631074; AID72446; AID764976
Sodium- and chloride-dependent GABA transporter 2Homo sapiens (human)IC50 (µMol)11.90006.20006.20006.2000AID1188931; AID764977
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (50)

Processvia Protein(s)Taxonomy
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
memorySodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
associative learningSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
synapse organizationSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
chemical synaptic transmissionSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
response to toxic substanceSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
response to sucroseSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
response to inorganic substanceSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
response to lead ionSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
positive regulation of gamma-aminobutyric acid secretionSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
response to purine-containing compoundSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
negative regulation of synaptic transmission, GABAergicSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
response to estradiolSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
response to cocaineSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
response to calcium ionSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
gamma-aminobutyric acid reuptakeSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
gamma-aminobutyric acid importSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
inorganic anion import across plasma membraneSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
sodium ion import across plasma membraneSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
transport across blood-brain barrierSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
chloride transmembrane transportSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
sodium ion transmembrane transportSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
amino acid transportSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
amino acid transmembrane transportSodium- and chloride-dependent betaine transporterHomo sapiens (human)
amino acid transportSodium- and chloride-dependent betaine transporterHomo sapiens (human)
monocarboxylic acid transportSodium- and chloride-dependent betaine transporterHomo sapiens (human)
gamma-aminobutyric acid transportSodium- and chloride-dependent betaine transporterHomo sapiens (human)
glycine betaine transportSodium- and chloride-dependent betaine transporterHomo sapiens (human)
gamma-aminobutyric acid reuptakeSodium- and chloride-dependent betaine transporterHomo sapiens (human)
sodium ion transmembrane transportSodium- and chloride-dependent betaine transporterHomo sapiens (human)
amino acid transmembrane transportSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
response to xenobiotic stimulusSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
monocarboxylic acid transportSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
taurine transmembrane transportSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
gamma-aminobutyric acid reuptakeSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
sodium ion transmembrane transportSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
amino acid transportSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
nitrogen compound transportSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
monocarboxylic acid transportSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
taurine transmembrane transportSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
creatine transmembrane transportSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
gamma-aminobutyric acid reuptakeSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
gamma-aminobutyric acid importSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
nitrogen compound transportSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
amino acid import across plasma membraneSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
transport across blood-brain barrierSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
amino acid transportSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
sodium ion transmembrane transportSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (35)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
gamma-aminobutyric acid:sodium:chloride symporter activitySodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
protein bindingSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
gamma-aminobutyric acid transmembrane transporter activitySodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
sodium:chloride symporter activitySodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
identical protein bindingSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
metal ion bindingSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
gamma-aminobutyric acid:sodium:chloride symporter activitySodium- and chloride-dependent betaine transporterHomo sapiens (human)
protein bindingSodium- and chloride-dependent betaine transporterHomo sapiens (human)
monocarboxylic acid transmembrane transporter activitySodium- and chloride-dependent betaine transporterHomo sapiens (human)
amino acid transmembrane transporter activitySodium- and chloride-dependent betaine transporterHomo sapiens (human)
gamma-aminobutyric acid:sodium:chloride symporter activitySodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
taurine:sodium symporter activitySodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
monocarboxylic acid transmembrane transporter activitySodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
amino acid bindingSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
amino acid:sodium symporter activitySodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
creatine transmembrane transporter activitySodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
gamma-aminobutyric acid:sodium:chloride symporter activitySodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
taurine transmembrane transporter activitySodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
taurine:sodium symporter activitySodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
monocarboxylic acid transmembrane transporter activitySodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
amino acid transmembrane transporter activitySodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
gamma-aminobutyric acid transmembrane transporter activitySodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (15)

Processvia Protein(s)Taxonomy
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
plasma membraneSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
plasma membraneSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
membraneSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
axonSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
presynaptic membraneSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
neuronal cell bodySodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
postsynaptic membraneSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
GABA-ergic synapseSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
axonSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
cell surfaceSodium- and chloride-dependent GABA transporter 1Homo sapiens (human)
plasma membraneSodium- and chloride-dependent betaine transporterHomo sapiens (human)
membraneSodium- and chloride-dependent betaine transporterHomo sapiens (human)
basolateral plasma membraneSodium- and chloride-dependent betaine transporterHomo sapiens (human)
presynapseSodium- and chloride-dependent betaine transporterHomo sapiens (human)
cell projectionSodium- and chloride-dependent betaine transporterHomo sapiens (human)
plasma membraneSodium- and chloride-dependent betaine transporterHomo sapiens (human)
plasma membraneSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
membraneSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
presynaptic membraneSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
postsynaptic membraneSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
GABA-ergic synapseSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
plasma membraneSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
cell projectionSodium- and chloride-dependent GABA transporter 3Homo sapiens (human)
plasma membraneSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
basolateral plasma membraneSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
extracellular exosomeSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
presynapseSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
plasma membraneSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
cell projectionSodium- and chloride-dependent GABA transporter 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (99)

Assay IDTitleYearJournalArticle
AID72446Inhibitory activity against human sodium and chloride dependent GABA transporter 31994Journal of medicinal chemistry, Jul-22, Volume: 37, Issue:15
Design, synthesis and evaluation of substituted triarylnipecotic acid derivatives as GABA uptake inhibitors: identification of a ligand with moderate affinity and selectivity for the cloned human GABA transporter GAT-3.
AID1188933Inhibition of human BGT1 transfected in CHO cells assessed as [3H]GABA uptake after 20 mins by liquid scintillation counting analysis2014ACS medicinal chemistry letters, Aug-14, Volume: 5, Issue:8
Conformationally Restricted GABA with Bicyclo[3.1.0]hexane Backbone as the First Highly Selective BGT-1 Inhibitor.
AID370903Inhibition of [3H]GABA uptake at mouse GAT1 expressed in HEK cells2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4.
AID764585Analgesic activity in albino Swiss CD-1 mouse assessed as reduction in formalin-induced inflammatory pain at 30 mg/kg, ip administered 30 mins prior to formalin challenge measured up to 5 mins relative to control2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID764590Analgesic effect in albino Swiss CD-1 mouse assessed as inhibition of acetic acid-induced writhing at 3.75 mg/kg, ip administered 30 mins prior to acetic acid challenge measured for 30 mins relative to control2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID1573771Inhibition of mouse GAT4 expressed in HEK cells assessed as reduction in [3H]GABA uptake by measuring remaining [3H]GABA uptake levels preincubated for 25 mins followed by [3H]GABA addition and measured after 4 mins by microbeta liquid scintillation count2019Bioorganic & medicinal chemistry, 01-01, Volume: 27, Issue:1
Generation and screening of pseudostatic hydrazone libraries derived from 5-substituted nipecotic acid derivatives at the GABA transporter mGAT4.
AID1778999Inhibition of mouse GAT3 expressed in human HEK293 cell line assessed as inhibition of [3H]GABA uptake measured after 40 mins by LC-ESI-MS/MS analysis2021European journal of medicinal chemistry, Oct-05, Volume: 221Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity.
AID764592Analgesic effect in albino Swiss CD-1 mouse assessed as inhibition of acetic acid-induced writhing at 15 mg/kg, ip administered 30 mins prior to acetic acid challenge measured for 30 mins relative to control2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID1779018Inhibition of mouse GAT2 expressed in human HEK293 cell line assessed as inhibition of [3H]GABA uptake at 100 uM measured after 40 mins by LC-ESI-MS/MS analysis2021European journal of medicinal chemistry, Oct-05, Volume: 221Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity.
AID1192143Inhibition of mouse GAT4 expressed in HEK293 cells by [3H]GABA uptake assay2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
Design, synthesis and SAR studies of GABA uptake inhibitors derived from 2-substituted pyrrolidine-2-yl-acetic acids.
AID764598Inhibition of mouse GAT2-mediated [3H]GABA uptake stably transfected in HEK293 cells assessed as residual uptake at 100 uM relative to control2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID1573772Inhibition of human GAT3 expressed in COS7 cells assessed as reduction in [2H6]GABA uptake preincubated for 25 mins followed by [2H6]GABA addition and measured after 6 mins by LC-MS/MS analysis2019Bioorganic & medicinal chemistry, 01-01, Volume: 27, Issue:1
Generation and screening of pseudostatic hydrazone libraries derived from 5-substituted nipecotic acid derivatives at the GABA transporter mGAT4.
AID1272002Inhibition of mouse GAT1 mediated [3]GABA uptake expressed in HEK293 cells after 3 mins by scintillation counting2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Straightforward and effective synthesis of γ-aminobutyric acid transporter subtype 2-selective acyl-substituted azaspiro[4.5]decanes.
AID1188934Selectivity index, ratio of IC50 for human GAT3 to IC50 for human BGT12014ACS medicinal chemistry letters, Aug-14, Volume: 5, Issue:8
Conformationally Restricted GABA with Bicyclo[3.1.0]hexane Backbone as the First Highly Selective BGT-1 Inhibitor.
AID1498407Inhibition of [2H10]NO 711 binding to mouse GAT1 expressed in HEK293 cell membranes after 40 mins by LC-ESI-MS-MS analysis2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with an alkyne spacer as GABA uptake inhibitors.
AID1779000Inhibition of mouse GAT4 expressed in human HEK293 cell line assessed as inhibition of [3H]GABA uptake measured after 40 mins by LC-ESI-MS/MS analysis2021European journal of medicinal chemistry, Oct-05, Volume: 221Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity.
AID1192156Inhibition of mouse GAT2 expressed in HEK293 cells assessed as remaining [3H]GABA uptake at 100 uM by [3H]GABA uptake assay2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
Design, synthesis and SAR studies of GABA uptake inhibitors derived from 2-substituted pyrrolidine-2-yl-acetic acids.
AID595476Inhibition of mouse GAT4-mediated [3H]GABA uptake expressed in human HEK cells2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.
AID764602Inhibition of mouse GAT1-mediated [3H]GABA uptake stably transfected in HEK293 cells2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID487220Selectivity ratio of IC50 for GAT3 to IC50 for GAT12010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Azetidine derivatives as novel gamma-aminobutyric acid uptake inhibitors: synthesis, biological evaluation, and structure-activity relationship.
AID764588Analgesic effect in ip dosed albino Swiss CD-1 mouse assessed as inhibition of acetic acid-induced writhing administered 30 mins prior to acetic acid challenge measured for 30 mins2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID595475Inhibition of mouse GAT3-mediated [3H]GABA uptake expressed in human HEK cells2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.
AID631158Selectivity ratio of IC50 for mouse GAT4 to IC50 for mouse GAT22011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Aminomethyltetrazoles as potential inhibitors of the γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID764975Inhibition of human BGT1 transfected in CHO cells assessed as [3H]GABA uptake after 20 mins by liquid scintillation counting analysis2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Cyclopropane-based conformational restriction of GABA by a stereochemical diversity-oriented strategy: identification of an efficient lead for potent inhibitors of GABA transports.
AID1615010Inhibition of mouse GAT4 expressed in HEK293 cells assessed as reduction in [3H]GABA uptake preincubated for 25 mins followed by [3H]GABA addition and measured after 4 mins by microbeta liquid scintillation counting method2019Bioorganic & medicinal chemistry, 03-01, Volume: 27, Issue:5
Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with a cis-alkene spacer as GABA uptake inhibitors.
AID764589Analgesic effect in albino Swiss CD-1 mouse assessed as inhibition of acetic acid-induced writhing at 7.5 mg/kg, ip administered 30 mins prior to acetic acid challenge measured for 30 mins relative to control2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID1272003Inhibition of mouse BGT1 mediated [3]GABA uptake expressed in HEK293 cells after 3 mins by scintillation counting2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Straightforward and effective synthesis of γ-aminobutyric acid transporter subtype 2-selective acyl-substituted azaspiro[4.5]decanes.
AID1188931Inhibition of human GAT2 transfected in CHO cells assessed as [3H]GABA uptake after 20 mins by liquid scintillation counting analysis2014ACS medicinal chemistry letters, Aug-14, Volume: 5, Issue:8
Conformationally Restricted GABA with Bicyclo[3.1.0]hexane Backbone as the First Highly Selective BGT-1 Inhibitor.
AID1188930Inhibition of human GAT1 transfected in CHO cells assessed as [3H]GABA uptake after 20 mins by liquid scintillation counting analysis2014ACS medicinal chemistry letters, Aug-14, Volume: 5, Issue:8
Conformationally Restricted GABA with Bicyclo[3.1.0]hexane Backbone as the First Highly Selective BGT-1 Inhibitor.
AID1736158Inhibition of mouse GAT3 expressed in HEK293 cell line assessed as inhibition of [3H]GABA uptake measured after 35 mins by liquid scintillation method2020European journal of medicinal chemistry, Feb-15, Volume: 188Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice.
AID1156746Anticonvulsant activity against pilocarpine-induced seizure in albino Swiss (CD-1) mouse assessed as prolongation of latency time to death at 100 mg/kg, ip administered 60 mins before pilocarpine challenge2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
AID631075Inhibition of human BGT1 assessed as [3H]GABA uptake2011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Aminomethyltetrazoles as potential inhibitors of the γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID759054Inhibition of GABA uptake at murine GAT-3 expressed in HEK293 cells2013European journal of medicinal chemistry, Jul, Volume: 65Synthesis of N-substituted acyclic β-amino acids and their investigation as GABA uptake inhibitors.
AID631076Inhibition of rat GAT2 assessed as [3H]GABA uptake2011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Aminomethyltetrazoles as potential inhibitors of the γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID764976Inhibition of human GAT3 transfected in CHO cells assessed as [3H]GABA uptake after 20 mins by liquid scintillation counting analysis2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Cyclopropane-based conformational restriction of GABA by a stereochemical diversity-oriented strategy: identification of an efficient lead for potent inhibitors of GABA transports.
AID370908Inhibition of [3H]GABA uptake at mouse GAT2 expressed in HEK cells assessed as remaining [3H]GABA uptake at 100 uM relative to control2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4.
AID1156748Anticonvulsant activity against pilocarpine-induced seizure in albino Swiss (CD-1) mouse assessed as prolongation of latency time to seizures at 200 mg/kg, ip administered 60 mins before pilocarpine challenge2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
AID595473Inhibition of mouse GAT1-mediated [3H]GABA uptake expressed in human HEK cells2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.
AID631073Inhibition of human GAT1 assessed as [3H]GABA uptake2011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Aminomethyltetrazoles as potential inhibitors of the γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID1573769Inhibition of mouse GAT3 expressed in HEK cells assessed as reduction in [3H]GABA uptake by measuring remaining [3H]GABA uptake levels preincubated for 25 mins followed by [3H]GABA addition and measured after 4 mins by microbeta liquid scintillation count2019Bioorganic & medicinal chemistry, 01-01, Volume: 27, Issue:1
Generation and screening of pseudostatic hydrazone libraries derived from 5-substituted nipecotic acid derivatives at the GABA transporter mGAT4.
AID595474Inhibition of mouse GAT2-mediated [3H]GABA uptake expressed in human HEK cells2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.
AID1498411Inhibition of mouse GAT2 expressed in HEK293 cells assessed as decrease in [3H]GABA uptake at 100 uM preincubated for 25 mins followed by [3H]GABA addition measured after 10 mins by liquid scintillation counting analysis relative to control2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with an alkyne spacer as GABA uptake inhibitors.
AID1156750Anticonvulsant activity against pilocarpine-induced seizure in albino Swiss (CD-1) mouse assessed as prolongation of latency time to death at 200 mg/kg, ip administered 60 mins before pilocarpine challenge2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
AID1498412Inhibition of mouse GAT3 expressed in HEK293 cells assessed as decrease in [3H]GABA uptake preincubated for 25 mins followed by [3H]GABA addition measured after 4 mins by liquid scintillation counting analysis2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with an alkyne spacer as GABA uptake inhibitors.
AID1156721Inhibition of mouse GAT1 expressed in HEK293 cells assessed as decrease in [3H]GABA uptake2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
AID1195451Inhibition of mouse mGAT4 expressed in HEK293 cells assessed as inhibition of [3H]GABA uptake after 3 mins incubation by TopCount microplate scintillation counting analysis2015Bioorganic & medicinal chemistry, May-15, Volume: 23, Issue:10
Structure activity relationship of selective GABA uptake inhibitors.
AID764978Inhibition of human GAT1 transfected in CHO cells assessed as [3H]GABA uptake after 20 mins by liquid scintillation counting analysis2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Cyclopropane-based conformational restriction of GABA by a stereochemical diversity-oriented strategy: identification of an efficient lead for potent inhibitors of GABA transports.
AID1156751Antidepressant-like activity in albino Swiss (CD-1) mouse assessed as reduction in immobility time at 15 mg/kg, ip by forced swim test2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
AID1778993Inhibition of mouse GAT1 expressed in human HEK293 cell line assessed as inhibition of [3H]GABA uptake measured after 40 mins by LC-ESI-MS/MS analysis2021European journal of medicinal chemistry, Oct-05, Volume: 221Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity.
AID487212Inhibition of GAT1-mediated [3H]GABA uptake in bovine brain stem2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Azetidine derivatives as novel gamma-aminobutyric acid uptake inhibitors: synthesis, biological evaluation, and structure-activity relationship.
AID759053Inhibition of GABA uptake at murine GAT-2 expressed in HEK293 cells2013European journal of medicinal chemistry, Jul, Volume: 65Synthesis of N-substituted acyclic β-amino acids and their investigation as GABA uptake inhibitors.
AID1498409Inhibition of mouse GAT1 expressed in HEK293 cells assessed as decrease in [3H]GABA uptake preincubated for 25 mins followed by [3H]GABA addition measured after 4 mins by liquid scintillation counting analysis2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with an alkyne spacer as GABA uptake inhibitors.
AID1498414Inhibition of mouse GAT4 expressed in HEK293 cells assessed as decrease in [3H]GABA uptake preincubated for 25 mins followed by [3H]GABA addition measured after 4 mins by liquid scintillation counting analysis2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with an alkyne spacer as GABA uptake inhibitors.
AID1573765Inhibition of mouse GAT1 expressed in HEK cells assessed as reduction in [3H]GABA uptake by measuring remaining [3H]GABA uptake levels preincubated for 25 mins followed by [3H]GABA addition and measured after 4 mins by microbeta liquid scintillation count2019Bioorganic & medicinal chemistry, 01-01, Volume: 27, Issue:1
Generation and screening of pseudostatic hydrazone libraries derived from 5-substituted nipecotic acid derivatives at the GABA transporter mGAT4.
AID764977Inhibition of human GAT2 transfected in CHO cells assessed as [3H]GABA uptake after 20 mins by liquid scintillation counting analysis2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Cyclopropane-based conformational restriction of GABA by a stereochemical diversity-oriented strategy: identification of an efficient lead for potent inhibitors of GABA transports.
AID1156745Anticonvulsant activity against pilocarpine-induced seizure in albino Swiss (CD-1) mouse assessed as prolongation of latency time to seizures at 100 mg/kg, ip administered 60 mins before pilocarpine challenge2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
AID1615004Inhibition of mouse GAT1 expressed in HEK293 cells assessed as reduction in [3H]GABA uptake preincubated for 25 mins followed by [3H]GABA addition and measured after 4 mins by microbeta liquid scintillation counting method2019Bioorganic & medicinal chemistry, 03-01, Volume: 27, Issue:5
Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with a cis-alkene spacer as GABA uptake inhibitors.
AID764571Neurotoxicity in albino Swiss CD-1 mouse assessed as mean time spent on the rotarod with 6 rpm at 30 mg/kg, ip after 30 mins by rotarod test (Rvb = 60.0 +/- 0.0 seconds)2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID764570Neurotoxicity in albino Swiss CD-1 mouse assessed as mean time spent on the rotarod with 18 rpm at 30 mg/kg, ip after 30 mins by rotarod test (Rvb = 60.0 +/- 0.0 seconds)2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID1573768Inhibition of mouse GAT2 expressed in HEK cells assessed as reduction in [3H]GABA uptake at 100 uM by measuring remaining [3H]GABA uptake levels preincubated for 25 mins followed by [3H]GABA addition and measured after 4 mins by microbeta liquid scintilla2019Bioorganic & medicinal chemistry, 01-01, Volume: 27, Issue:1
Generation and screening of pseudostatic hydrazone libraries derived from 5-substituted nipecotic acid derivatives at the GABA transporter mGAT4.
AID1192137Inhibition of mouse GAT1 expressed in HEK293 cells by [3H]GABA uptake assay2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
Design, synthesis and SAR studies of GABA uptake inhibitors derived from 2-substituted pyrrolidine-2-yl-acetic acids.
AID1192141Inhibition of mouse GAT3 expressed in HEK293 cells by [3H]GABA uptake assay2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
Design, synthesis and SAR studies of GABA uptake inhibitors derived from 2-substituted pyrrolidine-2-yl-acetic acids.
AID487208Inhibition of GAT3-mediated [3H]GABA uptake in bovine brain stem2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Azetidine derivatives as novel gamma-aminobutyric acid uptake inhibitors: synthesis, biological evaluation, and structure-activity relationship.
AID631074Inhibition of human GAT3 assessed as [3H]GABA uptake2011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Aminomethyltetrazoles as potential inhibitors of the γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID1195449Inhibition of mouse mGAT2 expressed in HEK293 cells assessed as inhibition of [3H]GABA uptake after 3 mins incubation by TopCount microplate scintillation counting analysis2015Bioorganic & medicinal chemistry, May-15, Volume: 23, Issue:10
Structure activity relationship of selective GABA uptake inhibitors.
AID764581Analgesic activity in albino Swiss CD-1 mouse assessed as reduction in formalin-induced inflammatory pain at 30 mg/kg, ip administered 30 mins prior to formalin challenge measured for 15 to 30 mins relative to control2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID205447Inhibitory activity against rat GABA transporter-2 (rGAT2)1994Journal of medicinal chemistry, Jul-22, Volume: 37, Issue:15
Design, synthesis and evaluation of substituted triarylnipecotic acid derivatives as GABA uptake inhibitors: identification of a ligand with moderate affinity and selectivity for the cloned human GABA transporter GAT-3.
AID1195448Inhibition of mouse mGAT1 expressed in HEK293 cells assessed as inhibition of [3H]GABA uptake after 3 mins incubation by TopCount microplate scintillation counting analysis2015Bioorganic & medicinal chemistry, May-15, Volume: 23, Issue:10
Structure activity relationship of selective GABA uptake inhibitors.
AID764572Antinociceptive activity against formalin-induced inflammatory pain in albino Swiss CD-1 mouse assessed as duration of licking response at 30 mg/kg, ip administered 30 mins prior to formalin challenge measured for 15 to 30 mins (Rvb = 78.8 +/- 15.9 second2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID1615008Inhibition of mouse GAT3 expressed in HEK293 cells assessed as reduction in [3H]GABA uptake preincubated for 25 mins followed by [3H]GABA addition and measured after 4 mins by microbeta liquid scintillation counting method2019Bioorganic & medicinal chemistry, 03-01, Volume: 27, Issue:5
Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with a cis-alkene spacer as GABA uptake inhibitors.
AID1156754Antinociceptive activity in ip dosed albino Swiss (CD-1) mouse measured after 60 mins by hot plate test2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
AID1272004Inhibition of mouse GAT2 mediated [3]GABA uptake expressed in HEK293 cells after 3 mins by scintillation counting2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Straightforward and effective synthesis of γ-aminobutyric acid transporter subtype 2-selective acyl-substituted azaspiro[4.5]decanes.
AID1615007Inhibition of mouse GAT2 expressed in HEK293 cells assessed as remaining [3H]GABA uptake at 100 uM preincubated for 25 mins followed by [3H]GABA addition and measured after 10 mins by liquid scintillation counting method relative to control2019Bioorganic & medicinal chemistry, 03-01, Volume: 27, Issue:5
Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with a cis-alkene spacer as GABA uptake inhibitors.
AID759056Inhibition of GABA uptake at murine GAT-1 expressed in HEK293 cells2013European journal of medicinal chemistry, Jul, Volume: 65Synthesis of N-substituted acyclic β-amino acids and their investigation as GABA uptake inhibitors.
AID205304Inhibition of human GABA transporter (hBGT-1) activity.1994Journal of medicinal chemistry, Jul-22, Volume: 37, Issue:15
Design, synthesis and evaluation of substituted triarylnipecotic acid derivatives as GABA uptake inhibitors: identification of a ligand with moderate affinity and selectivity for the cloned human GABA transporter GAT-3.
AID764576Antinociceptive activity against formalin-induced inflammatory pain in albino Swiss CD-1 mouse assessed as duration of licking response at 30 mg/kg, ip administered 30 mins prior to formalin challenge measured up to 5 mins (Rvb = 34.8 +/- 9.4 seconds)2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID759055Inhibition of GABA uptake at murine BGT-1 expressed in HEK293 cells2013European journal of medicinal chemistry, Jul, Volume: 65Synthesis of N-substituted acyclic β-amino acids and their investigation as GABA uptake inhibitors.
AID631159Selectivity ratio of IC50 for mouse GAT4 to IC50 for mouse GAT12011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Aminomethyltetrazoles as potential inhibitors of the γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID1156727Anticonvulsant activity in albino Swiss (CD-1) mouse assessed as current intensity required to induce 50% tonic hind limb extensions at 100 mg/kg, ip after 60 mins by electroconvulsive threshold test (Rvb = 6.61 mA)2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
AID764599Inhibition of mouse GAT4-mediated [3H]GABA uptake stably transfected in HEK293 cells2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID1615003Displacement of NO711 from mouse GAT1 expressed in stable HEK293 cell membranes preincubated for 10 mins followed by NO711 addition and measured after 40 mins by LC-ESI-MS/MS analysis2019Bioorganic & medicinal chemistry, 03-01, Volume: 27, Issue:5
Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with a cis-alkene spacer as GABA uptake inhibitors.
AID1736188Inhibition of mouse GAT4 expressed in HEK293 cell line assessed as inhibition of [3H]GABA uptake measured after 35 mins by liquid scintillation method2020European journal of medicinal chemistry, Feb-15, Volume: 188Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice.
AID1156722Inhibition of mouse GAT2 expressed in HEK293 cells assessed as decrease in [3H]GABA uptake2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
AID1156724Inhibition of mouse GAT4 expressed in HEK293 cells assessed as decrease in [3H]GABA uptake2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
AID1156723Inhibition of mouse GAT3 expressed in HEK293 cells assessed as decrease in [3H]GABA uptake2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
AID1736160Inhibition of mouse GAT1 expressed in HEK293 cell line assessed as inhibition of [3H]GABA uptake measured after 35 mins by liquid scintillation method2020European journal of medicinal chemistry, Feb-15, Volume: 188Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice.
AID1156726Displacement of NO711 from mouse GAT1 expressed in HEK293 cells by LC-MS/MS analysis2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
AID1195450Inhibition of mouse mGAT3 expressed in HEK293 cells assessed as inhibition of [3H]GABA uptake after 3 mins incubation by TopCount microplate scintillation counting analysis2015Bioorganic & medicinal chemistry, May-15, Volume: 23, Issue:10
Structure activity relationship of selective GABA uptake inhibitors.
AID764569Neurotoxicity in albino Swiss CD-1 mouse assessed as mean time spent on the rotarod with 24 rpm at 30 mg/kg, ip after 30 mins by rotarod test (Rvb = 60.0 +/- 0.0 seconds)2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID764604Antinociceptive activity in albino Swiss CD-1 mouse assessed as prolongation of latency time at 30 mg/kg, ip administered 30 mins prior to test by hot plate test2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID1188932Inhibition of human GAT3 transfected in CHO cells assessed as [3H]GABA uptake after 20 mins by liquid scintillation counting analysis2014ACS medicinal chemistry letters, Aug-14, Volume: 5, Issue:8
Conformationally Restricted GABA with Bicyclo[3.1.0]hexane Backbone as the First Highly Selective BGT-1 Inhibitor.
AID764600Binding affinity to mouse GAT1 stably transfected in HEK293 cells by NO-711 binding assay2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
AID370906Inhibition of [3H]GABA uptake at mouse GAT4 expressed in HEK cells2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4.
AID370905Inhibition of [3H]GABA uptake at mouse GAT3 expressed in HEK cells2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4.
AID205303Inhibitory activity against human GABA transporter-1 (hGAT1)1994Journal of medicinal chemistry, Jul-22, Volume: 37, Issue:15
Design, synthesis and evaluation of substituted triarylnipecotic acid derivatives as GABA uptake inhibitors: identification of a ligand with moderate affinity and selectivity for the cloned human GABA transporter GAT-3.
AID1272005Inhibition of mouse GAT3 mediated [3]GABA uptake expressed in HEK293 cells after 3 mins by scintillation counting2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Straightforward and effective synthesis of γ-aminobutyric acid transporter subtype 2-selective acyl-substituted azaspiro[4.5]decanes.
AID487217Binding affinity to GAT32010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Azetidine derivatives as novel gamma-aminobutyric acid uptake inhibitors: synthesis, biological evaluation, and structure-activity relationship.
AID1156752Antidepressant-like activity in albino Swiss (CD-1) mouse assessed as reduction in immobility time at 30 mg/kg, ip by forced swim test2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
AID1346957Rat GAT2 (GABA transporter subfamily)1994Receptors & channels, , Volume: 2, Issue:3
Cloning of the human homologue of the GABA transporter GAT-3 and identification of a novel inhibitor with selectivity for this site.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (10.53)18.2507
2000's1 (5.26)29.6817
2010's14 (73.68)24.3611
2020's2 (10.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]